Apotex recalls hypertension capsules that may be empty; Tobacco gets bioengineered;

> Apotex, is voluntarily recalling Lot JR2178 of hypertension drug Apo-Ramipril 5-mg capsules because some of the capsules are empty. Story

> Inserogen, a startup formed by a Ph.D. from the Universtiy of California-Davis, intends to use its "SwiftVax" plants to turn tobacco into cheap biological factories for bioengineered proteins. Story

> A survey of U.S. and EU pharmaceutical executives found a significant number who believe that "the business model is broken" and needs to be addressed by redeploying resources. Release

Suggested Articles

Neopharma, which has been buying and building plants for several years, is buying a sterile injectables plant and assets in Japan from India’s Lupin. 

Already knocked by the FDA four times this year, Dr. Reddy’s now has a fifth Form 483 to dwell on. This time it’s at a plant with a history of faults.

In a warning letter, the FDA details how a Chinese OTC drugmaker handed over documents faked just for the agency's inspection—and admitted it.